-
EP3094330
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3094330
| EP3094330 - TREATMENT OF CROHN'S DISEASE USING LOW DOSES OF LAQUINIMOD [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.08.2018 Database last updated on 20.07.2024 | |
| Former | Request for examination was made Status updated on 03.05.2018 | Most recent event Tooltip | 17.08.2018 | Application deemed to be withdrawn | published on 19.09.2018 [2018/38] | Applicant(s) | For all designated states Teva Pharmaceutical Industries Ltd 5 Basel Street PO Box 3190 49131 Petach Tikva / IL | [2016/47] | Inventor(s) | 01 /
BROWN, Kurt, A. 634 Moreno Road Narberth, PA 19072 / US | 02 /
SORANI, Ella No. 2 Hakinor Street 6092000 Kadima / IL | [2016/47] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] |
| Former [2016/47] | D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 15737558.5 | 15.01.2015 | [2016/47] | WO2015US11587 | Priority number, date | US201461928995P | 17.01.2014 Original published format: US 201461928995 P | [2016/47] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2015109083 | Date: | 23.07.2015 | Language: | EN | [2015/29] | Type: | A1 Application with search report | No.: | EP3094330 | Date: | 23.11.2016 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.07.2015 takes the place of the publication of the European patent application. | [2016/47] | Search report(s) | International search report - published on: | US | 23.07.2015 | (Supplementary) European search report - dispatched on: | EP | 25.08.2017 | Classification | IPC: | A61K31/47, A61K31/4704, A61P37/02, A61K9/48 | [2017/39] | CPC: |
A61K31/4704 (EP,US);
A61K9/48 (US);
A61P37/02 (EP)
|
| Former IPC [2016/47] | A61K31/47, A61K31/4704, A61P37/02 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2016/47] | Extension states | BA | 23.06.2016 | ME | 23.06.2016 | Title | German: | BEHANDLUNG VON MORBUS CROHN UNTER VERWENDUNG VON NIEDRIGDOSIERTEM LAQUINIMOD | [2016/47] | English: | TREATMENT OF CROHN'S DISEASE USING LOW DOSES OF LAQUINIMOD | [2016/47] | French: | TRAITEMENT DE LA MALADIE DE CROHN AU MOYEN DE FAIBLES DOSES DE LAQUINIMOD | [2016/47] | Entry into regional phase | 23.06.2016 | National basic fee paid | 23.06.2016 | Search fee paid | 23.06.2016 | Designation fee(s) paid | 23.06.2016 | Examination fee paid | Examination procedure | 23.06.2016 | Examination requested [2016/47] | 24.02.2017 | Amendment by applicant (claims and/or description) | 23.03.2018 | Application deemed to be withdrawn, date of legal effect [2018/38] | 04.05.2018 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2018/38] | Fees paid | Renewal fee | 20.01.2017 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.01.2018 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XDI]US2011027219 (TARCIC NORA [IL], et al) [XD] 14,15 * claims 1-25 * * paragraph [0001] - paragraph [0195] * [I] 1-13 | International search | [X]WO2013116657 (TEVA PHARMA [IL], et al); | [Y]WO2013016684 (TEVA PHARMA [IL], et al); | [Y]WO2012078591 (TEVA PHARMA [IL], et al); | [A]US7989473 (PATASHNIK SHULAMIT [IL], et al) |